ESCMID:izjava za tisak o NDM-1 otpornim sojevima

Autor: Web-urednik (Kosalec)
23.08.2010, 13:15

PRESS STATEMENT
Report of new “superbugs” emphasises ill-preparedness across  Europe to meet this emerging public health challenge  
12 AUGUST 2010: Research just published that identifies new highly antibioticresistant  bacteria reinforces the frequency with which similar strains of so-called  “superbugs” are being discovered across Europe, according to the European Society  of Clinical Microbiology and Infectious Diseases (ESCMID). 

The study by Professor Timothy Walsh from Cardiff University and colleagues,  published in The Lancet Infectious Diseases, reports the occurrence in several  common bacteria of a resistance mechanism called New Delhi metallo-betalactamase  (NDM-1) that makes those bacteria unresponsive to treatment with almost  all antibiotics, including ones often used as a last resort, called carbapenems.  “These latest reports on the rapid spread of drug-resistant bacteria reinforce the  nature and size of the problem that we face,” says Professor Giuseppe Cornaglia,  President of the European Society of Clinical Microbiology and Infectious Diseases.  “Across Europe we have been monitoring and reporting on the emergence of similar  carbapenem-resistant bacteria for the past 10 years, since their first appearance in  Verona, Italy. Experiences from countries such as Italy, Greece and Israel have  shown that if public health professionals do not have sufficient preparedness plans  and resources allocated, infection caused by carbapenem-resistant bacteria poses a  substantial threat to both patients and the healthcare system.“  ESCMID stresses that no new antibiotics to treat such infections are likely to be  available for at least 10 years, and that the public health community must step up  surveillance and monitoring efforts at both the national level and across multi-country  networks to track what infections are occurring and how best to respond.  “As a scientific society that reaches out to more than 33,000 microbiologists and  infectious diseases specialists in Europe and around the world, ESCMID has been
promoting a multifaceted approach to such infections that focuses first and foremost  on containment at all levels. We have to look at improving surveillance and infection  control, at management strategies that go beyond reliance on antibiotics to control  infections, and at expanding the public health role of microbiologists in response to
such new threats", said Professor Cornaglia.
___________________________________________________________________
For more information or interviews contact: Claire Hoffman
claire.hoffman@bartley-robbs.co.uk Tel: +44 7977 440 353 or +44 208 892 5215
Visit www.escmid.org  The European Society of Clinical Microbiology and Infectious Diseases is a non-profit
organization whose mission is to improve the diagnosis, treatment and prevention of  infection-related diseases. This is achieved by promoting and supporting research,  education, training, and good medical practice.

LINK: Press statement

Galerija